Next DestiniesNext Destinies🃏All Jellicent cards
Ask about Jellicent
Jellicent #35 Pokémon card from Next Destinies

Jellicent 35/99

Next Destinies

Find this card on eBay

Affiliate link · we may earn commission

Jellicent #35 from Next Destinies currently trades at $1.29 raw, with PSA 10 copies reaching $50.91 — a 39.5x grade premium.
Current Prices (USD)
Ungraded
$1.29
PSA 7
$19.06
PSA 8
$19.06
PSA 9
$19.06
PSA 10
$50.91
ACE 10
BGS 10 Black
$330.00
CGC 10 Pristine
$56.00
Compare on eBay

Affiliate link · we may earn commission

Quick price facts

Jellicent 35/99 from Next Destinies has a current raw market value of $1.29.

Current raw value
$1.29
PSA 9 value
$19.06
PSA 10 value
$50.91
PSA 10 premium vs raw
39.5× raw
View all cards from Next Destinies
Collector Intel
39.5x
Raw → PSA 10
High-risk grade
14.8x
Raw → PSA 9
Grade multiplier

Calculated from price history, PSA population data, and market trends. Not financial advice.

Grading Calculator

Based on PSA Standard tier (~$25 USD). Assumes a perfect PSA 10 result — actual outcome depends on card condition.

⚠️ High-variance grade. PSA 10 is 39x the raw price. The expected value accounts for the realistic probability.
$1
Buy Raw
~$25
Grading Fee
PSA Standard
$51
PSA 10 Value
+$25
Best Case (PSA 10)
if you pull a 10
Grade Multiples vs Raw
PSA 9$1914.8x raw
PSA 10$5139.5x raw

Frequently asked questions

How much is Jellicent #35 from Next Destinies worth?+
Jellicent #35 from Next Destinies is currently worth Raw: $1.29, PSA 9: $19.06, PSA 10: $50.91 based on recent sold listings. Prices update daily from real eBay sales.
Is Jellicent #35 worth grading?+
The PSA 10 price of $50.91 is 39.5× the raw price of $1.29. After a ~$25 grading fee, a PSA 10 result would net approximately $49.62 — assuming the card grades a 10.
Where do PokePrices Jellicent #35 prices come from?+
Prices are tracked nightly from real sold listings on PriceCharting (raw, PSA 9 and PSA 10). PSA population data is sourced from PSA's public reports. We do not use asking prices — only confirmed sales.